MSB vs CRL, page-14

"The stratagy of cloaking their drug as a possible covid treatment has not fooled the FDA or convinced them to provide an easy path."

Do you mean prior to or post the FDA collaborating with MSB to give EAP and Phase 2/3 COVID19 trial approval? Regardless, something terrible must have gone wrong with the FDA internal process. Then the FDA compounded the error a few weeks later and granted EAP for Children with MIS-C- arrrh Houston we have a problem!

Or perhaps the NIH also got it wrong when then decided to sponsor the trials and support it with US$50M? Another internal process fail?

So, we are left with deciding between your credentials (none provided other than the ability to write a paragraphy, well sort of) and a zero evidence statement OR the rigorous internal decision making processes of the two most competent institutions in the USA.

Which one should we pick?? lol